Home Authors Posts by Michael Baxter

Michael Baxter

7865 POSTS 0 COMMENTS

Recent Articles

Talking About Current Stock Valuation: Sarepta Therapeutics, Inc. (SRPT), Synchrony Financial (SYF)

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), with a trailing 12-month price-to-sales ratio of 39.25, is now among the bigger bargains in its industry. The broad Biotechnology...

A Close Look At Valuations Of Aeterna Zentaris Inc. (AEZS), Alibaba Group Holding Limited...

Aeterna Zentaris Inc. (NASDAQ:AEZS) current P/S is an impressive 35.39. The overall Biotechnology group has an average P/S ratio of 132.83, which is significantly...

Don’t Let Stock Prices Fool You: Progenics Pharmaceuticals, Inc. (PGNX), Oracle Corporation (ORCL)

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) has a price-to-sales ratio of 35.36, well below its Biotechnology competitors. For the industry, the average P/S ratio sits at...